Hospital Acquired Infections Testing Kits Market Expected To Reach $7.19 Billion By 2030 As Growth Accelerates At 8.5% CAGR
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The hospital-acquired infections testing kits market has witnessed substantial growth in recent years and shows promising prospects for the future. With rising concerns about infections contracted within healthcare environments, this market is becoming increasingly vital for improving patient safety and optimizing infection control measures. Let’s explore the current market size, driving factors, key players, emerging trends, and regional insights shaping this important sector.
Hospital Acquired Infections Testing Kits Market Size and Expected Growth
The hospital-acquired infections testing kits market has grown significantly and is projected to expand further, increasing from $4.79 billion in 2025 to $5.19 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. This historical growth has been driven by enhanced infection surveillance in hospitals, a rise in antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, better infection control protocols, and the availability of advanced molecular diagnostic tools. Looking ahead, the market is forecast to reach $7.2 billion by 2030, maintaining the same CAGR of 8.5%. Factors such as heightened focus on early infection detection, increased investment in hospital safety infrastructure, broader adoption of rapid testing methods, growing demand for automated diagnostic workflows, and technological advances in molecular diagnostics will continue to underpin this growth. Key trends expected to influence the market include increased use of rapid diagnostic test kits, expanded molecular testing for hospital-acquired infections, integration of automated diagnostic instruments, growth in point-of-care infection testing, and a stronger emphasis on detecting multiple pathogens simultaneously.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
Expanding Healthcare Settings as a Major Growth Driver in the Hospital Acquired Infections Testing Kits Market
The growing number of healthcare facilities worldwide is playing a crucial role in driving demand for hospital-acquired infections testing kits. Healthcare settings encompass a variety of institutions such as acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, all of which require robust infection detection and prevention tools to ensure patient safety. For example, in May 2023, the American Hospital Association reported a significant increase in the total number of hospitals in the U.S., rising from 6,093 in 2022 to 60,129 in 2023. Alongside this, admissions in community hospitals also grew from over 31.3 million in 2022 to nearly 32 million in 2023. This expansion of healthcare infrastructure directly feeds into the rising need for infection testing kits.
Impact of Growing Surgical Procedures on the Hospital Acquired Infections Testing Kits Market
Another important factor boosting the hospital-acquired infections testing kits market is the rise in surgical procedures. Surgical operations, which involve incisions and require anesthesia or sedation, create potential entry points for infections, thus increasing the necessity for effective infection detection methods. The aging global population is a significant contributor to this trend, as older adults typically require more medical interventions related to chronic and age-related health issues. Evidence of this growth is seen in Australia, where hospitalizations involving surgery rose from 3.0 million cases in 2022-23 to 3.1 million cases in 2023-24, an increase of 100,000. Such increases in surgical volume naturally fuel demand for diagnostic kits that help monitor and manage postoperative infections.
Access The Complete Hospital Acquired Infections Testing Kits Market Report:
Product and Test Type Segments Defining the Hospital Acquired Infections Testing Kits Market
The hospital-acquired infections testing kits market is divided into several key segments that highlight its diverse product offerings and applications. By product, the market is split into consumables and reagents as well as instruments. Consumables and reagents include culture media used for pathogen isolation and identification, molecular testing reagents such as PCR kits, rapid test kits for various infections, and other related supplies like swabs and preservation solutions. Instrument categories cover automated analyzers for blood culture and pathogen identification, molecular diagnostic devices for PCR and other methods, microscopes, and incubators used for culturing samples. Test types focus on infections such as pneumonia, urinary tract infections, bloodstream infections, surgical site infections, MRSA infections, and others. Additionally, pathogen types are classified into viral, bacterial, and fungal, while application areas revolve around drug resistance testing and disease diagnostics.
Emerging Trends Shaping the Future of the Hospital Acquired Infections Testing Kits Market
Recent innovations in the hospital-acquired infections testing kits market emphasize the development of rapid point-of-care antimicrobial susceptibility testing (AST) solutions. These technologies enable faster diagnosis, guide more effective targeted therapies, and help combat the global challenge of antimicrobial resistance (AMR). Point-of-care AST systems use advanced microfluidic technology to quickly identify bacterial infections and assess antibiotic efficacy from patient samples, reducing diagnostic delays and improving treatment decisions. For example, in June 2023, Japan-based Sysmex Corporation launched the first point-of-care AST system in Europe capable of delivering results in just 30 minutes for urinary tract infections. This breakthrough technology supports antimicrobial stewardship by enabling timely and accurate antibiotic administration in primary care settings, contributing to global AMR mitigation efforts.
Key Players Leading the Hospital Acquired Infections Testing Kits Market
The hospital-acquired infections testing kits market features several prominent companies driving innovation and competition. Some of the major players include Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, and Vivacheck Lab. These organizations are actively involved in advancing diagnostic technologies and expanding product portfolios to meet growing market demands.
Regional Market Leadership and Growth Outlook in Hospital Acquired Infections Testing Kits
In 2025, North America held the largest share of the hospital-acquired infections testing kits market, reflecting its well-established healthcare infrastructure and high adoption of advanced diagnostic tools. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth during the forecast period, driven by increasing healthcare investments, expanding hospital networks, and rising awareness of infection control. The market analysis encompasses key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
